Regulation of ubiquitous 6-phosphofructo-2-kinase by the ubiquitin-proteasome proteolytic pathway during myogenic C2C12 cell differentiation

被引:30
作者
Riera, L [1 ]
Obach, M [1 ]
Navarro-Sabaté, A [1 ]
Duran, J [1 ]
Perales, JC [1 ]
Viñals, F [1 ]
Rosa, JL [1 ]
Ventura, F [1 ]
Bartrons, R [1 ]
机构
[1] Univ Barcelona, Dept Ciencias Fisiol 2, Unitat Bioquim & Biol Mol, E-08907 Lhospitalet De Llobregat, Spain
关键词
6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase; glycolysis; ubiquitin; proteasome; myogenic differentiation;
D O I
10.1016/S0014-5793(03)00808-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
6-Phosphofructo-2-kinase catalyzes the synthesis and degradation of fructose 2,6-bisphosphate, activator of phosphofructokinase-1 and inhibitor of fructose 1,6-bisphosphatase. These properties confer to this bifunctional enzyme a key role in the control of glycolysis and gluconeogenesis. Several mammalian isozymes generated by alternative splicing from four genes, designated pfkfb1-4, have been identified. The results presented in this study demonstrate the expression of the pfkfb3 gene in C2C12 cells and its downregulation during myogenic cell differentiation. We also show that the decrease of ubiquitous 6-phosphofructo-2-kinase isozyme levels, product of pfkfb3 gene, is due to its enhanced degradation through the ubiquitin-proteasome proteolytic pathway. (C) 2003 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 39 条
[1]   Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: Regulation by specific DNA binding [J].
Abu Hatoum, O ;
Gross-Mesilaty, S ;
Breitschopf, K ;
Hoffman, A ;
Gonen, H ;
Ciechanover, A ;
Bengal, E .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (10) :5670-5677
[2]  
Atsumi T, 2002, CANCER RES, V62, P5881
[3]  
Ausubel F.M., 1992, CURRENT PROTOCOLS MO
[4]   A NOVEL HUMAN-MUSCLE FACTOR RELATED TO BUT DISTINCT FROM MYOD1 INDUCES MYOGENIC CONVERSION IN 10T1/2 FIBROBLASTS [J].
BRAUN, T ;
BUSCHHAUSENDENKER, G ;
BOBER, E ;
TANNICH, E ;
ARNOLD, HH .
EMBO JOURNAL, 1989, 8 (03) :701-709
[5]   JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2 [J].
Chalaux, E ;
López-Rovira, T ;
Rosa, JL ;
Bartrons, R ;
Ventura, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :537-543
[6]   An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect [J].
Chesney, J ;
Mitchell, R ;
Benigni, F ;
Bacher, M ;
Spiegel, L ;
Al-Abed, Y ;
Han, JH ;
Metz, C ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3047-3052
[7]   HERC3 binding to and regulation by ubiquitin [J].
Cruz, C ;
Ventura, F ;
Bartrons, R ;
Rosa, JL .
FEBS LETTERS, 2001, 488 (1-2) :74-80
[8]   EXPRESSION OF A SINGLE TRANSFECTED CDNA CONVERTS FIBROBLASTS TO MYOBLASTS [J].
DAVIS, RL ;
WEINTRAUB, H ;
LASSAR, AB .
CELL, 1987, 51 (06) :987-1000
[9]   Prosome cytodistribution relative to desmin and actin filaments in dividing C2.7 myoblasts and during myotube formation in vitro [J].
DeConto, F ;
Missorini, S ;
Arcangeletti, C ;
Pinardi, F ;
Montarras, D ;
Pinset, C ;
Vassy, J ;
Geraud, G ;
Chezzi, C ;
Scherrer, K .
EXPERIMENTAL CELL RESEARCH, 1997, 233 (01) :99-117
[10]   A GENE WITH HOMOLOGY TO THE MYC SIMILARITY REGION OF MYOD1 IS EXPRESSED DURING MYOGENESIS AND IS SUFFICIENT TO ACTIVATE THE MUSCLE DIFFERENTIATION PROGRAM [J].
EDMONDSON, DG ;
OLSON, EN .
GENES & DEVELOPMENT, 1989, 3 (05) :628-640